Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1972 1
1973 1
1976 1
1978 2
1979 2
1980 4
1981 4
1982 2
1983 1
1984 2
1985 1
1988 3
1989 2
1990 1
1991 1
1993 3
1994 7
1995 10
1996 5
1997 5
1999 3
2000 5
2001 4
2002 5
2003 3
2004 6
2005 2
2006 6
2007 9
2008 11
2009 12
2010 14
2011 12
2012 20
2013 18
2014 16
2015 17
2016 21
2017 16
2018 16
2019 22
2020 36
2021 44
2022 31
Text availability
Article attribute
Article type
Publication date

Search Results

376 results
Results by year
Filters applied: . Clear all
Page 1
A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration.
Raso A, Dirkx E, Sampaio-Pinto V, El Azzouzi H, Cubero RJ, Sorensen DW, Ottaviani L, Olieslagers S, Huibers MM, de Weger R, Siddiqi S, Moimas S, Torrini C, Zentillin L, Braga L, Nascimento DS, da Costa Martins PA, van Berlo JH, Zacchigna S, Giacca M, De Windt LJ. Raso A, et al. Among authors: siddiqi s. Nat Commun. 2021 Aug 10;12(1):4808. doi: 10.1038/s41467-021-25211-4. Nat Commun. 2021. PMID: 34376683 Free PMC article.
Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease.
Siddiqi SH, Schaper FLWVJ, Horn A, Hsu J, Padmanabhan JL, Brodtmann A, Cash RFH, Corbetta M, Choi KS, Dougherty DD, Egorova N, Fitzgerald PB, George MS, Gozzi SA, Irmen F, Kuhn AA, Johnson KA, Naidech AM, Pascual-Leone A, Phan TG, Rouhl RPW, Taylor SF, Voss JL, Zalesky A, Grafman JH, Mayberg HS, Fox MD. Siddiqi SH, et al. Nat Hum Behav. 2021 Dec;5(12):1707-1716. doi: 10.1038/s41562-021-01161-1. Epub 2021 Jul 8. Nat Hum Behav. 2021. PMID: 34239076 Free PMC article.
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer.
Perets R, Bar J, Rasco DW, Ahn MJ, Yoh K, Kim DW, Nagrial A, Satouchi M, Lee DH, Spigel DR, Kotasek D, Gutierrez M, Niu J, Siddiqi S, Li X, Cyrus J, Chackerian A, Chain A, Altura RA, Cho BC. Perets R, et al. Among authors: siddiqi s. Ann Oncol. 2021 Mar;32(3):395-403. doi: 10.1016/j.annonc.2020.11.020. Epub 2020 Dec 2. Ann Oncol. 2021. PMID: 33276076 Free article. Clinical Trial.
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes [Internet].
Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, Pfyffer GE, Ridderhof JC, Siddiqi SH, Wallace RJ Jr, Warren NG, Witebsky FG. Woods GL, et al. Among authors: siddiqi sh. 2nd edition. Wayne (PA): Clinical and Laboratory Standards Institute; 2011 Mar. Report No.: M24-A2. 2nd edition. Wayne (PA): Clinical and Laboratory Standards Institute; 2011 Mar. Report No.: M24-A2. PMID: 31339680 Free Books & Documents. Review.
First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Siu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror C. Siu LL, et al. Among authors: siddiqi s. Clin Cancer Res. 2022 Jan 1;28(1):57-70. doi: 10.1158/1078-0432.CCR-21-2160. Epub 2021 Oct 1. Clin Cancer Res. 2022. PMID: 34598945
Pruritus ani.
Siddiqi S, Vijay V, Ward M, Mahendran R, Warren S. Siddiqi S, et al. Ann R Coll Surg Engl. 2008 Sep;90(6):457-63. doi: 10.1308/003588408X317940. Ann R Coll Surg Engl. 2008. PMID: 18765023 Free PMC article. Review.
376 results